1.33
6.40%
0.08
After Hours:
1.26
-0.07
-5.26%
Processa Pharmaceuticals Inc Stock (PCSA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Operating Income/Loss |
13.77%
-2.8096
|
-2.4695 | -2.1676 | -2.7145 | -4.1055 |
Income/Loss From Continuing Operations Before Tax |
13.37%
-2.7264
|
-2.4049 | -2.082 | -2.6126 | -4.0221 |
Income/Loss From Continuing Operations After Tax |
13.37%
-2.7264
|
-2.4049 | -2.082 | -2.6126 | -4.0221 |
Net Income/Loss
|
13.37%
-2.7264
|
-2.4049 | -2.082 | -2.6126 | -4.0221 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
110.16%
2.4665
|
-24.27 | 27.00 | 26.94 | 22.77 |
Diluted Average Shares |
110.16%
2.4665
|
-24.27 | 27.00 | 26.94 | -2.0708 |
Basic Earnings Per Share |
86.36%
-1.11
|
-8.14 | -0.08 | -0.10 | -0.18 |
Diluted Earnings Per Share |
86.36%
-1.11
|
-8.14 | -0.08 | -0.10 | -0.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):